Analystreport

BELLUS Health Inc. (NASDAQ: BLU) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $13.00 price target on the stock.

BELLUS Health Inc. - Common Shares  (BLU) 
Last bellus health inc. - common shares earnings: 11/14 07:00 am Check Earnings Report